Cargando…
MSC−sEV Treatment Polarizes Pro−Fibrotic M2 Macrophages without Exacerbating Liver Fibrosis in NASH
Mesenchymal stem/stromal cell small extracellular vesicles (MSC−sEVs) have shown promise in treating a wide range of animal models of various human diseases, which has led to their consideration for clinical translation. However, the possibility of contraindication for MSC−sEV use is an important co...
Autores principales: | Zhang, Bin, Zhang, Biyan, Lai, Ruenn Chai, Sim, Wei Kian, Lam, Kong Peng, Lim, Sai Kiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179074/ https://www.ncbi.nlm.nih.gov/pubmed/37175803 http://dx.doi.org/10.3390/ijms24098092 |
Ejemplares similares
-
Assessment of Tumorigenic Potential in Mesenchymal-Stem/Stromal-Cell-Derived Small Extracellular Vesicles (MSC-sEV)
por: Tan, Thong Teck, et al.
Publicado: (2021) -
MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA
por: Lai, Ruenn Chai, et al.
Publicado: (2016) -
HuMSC-EV induce monocyte/macrophage mobilization to orchestrate neovascularization in wound healing process following radiation injury
por: Loinard, Céline, et al.
Publicado: (2023) -
MSC exosome works through a protein-based mechanism of action
por: Toh, Wei Seong, et al.
Publicado: (2018) -
Neutrophil membrane engineered HucMSC sEVs alleviate cisplatin-induced AKI by enhancing cellular uptake and targeting
por: Wu, Peipei, et al.
Publicado: (2022)